Resistance of human cancer cells to multiple cytotoxic hydrophobic agents (multidrug resistance) is due to overexpression of the "MDRI" gene, whose product is the plasma membrane P-glycoprotein. Plasma membrane vesicles partially purified from multidrug-resistant human KB carcinoma cells, but not from drug-sensitive cells, accumulate [3H] 
Genetic and biochemical evidence based on the study of cell lines selected for resistance to multiple cytotoxic agents, including colchicine, vinblastine, doxorubicin, and actinomycin D, indicates that the multidrug-resistance pnenotype results from expression of the mdr gene, which encodes the plasma membrane protein P-glycoprotein (refs. 1-8, re- viewed in refs. 9 and 10). Analysis of cloned cDNAs for the human "MDRJ" gene and other mdr genes demonstrates that these related genes encode a protein of about 1280 amino acids with 12 transmembrane domains and two potential ATP binding sites homologous to ATP binding sites in bacterial transport proteins (11) (12) (13) . Because MDRJ-dependent multidrug resistance results from increased energydependent drug efflux (14) and because P-glycoprotein is located in the plasma membrane (15) , it seems likely that P-glycoprotein is an energy-dependent drug-efflux system for cytotoxic hydrophobic drugs.
Membrane vesicles derived from multidrug-resistant human KB carcinoma cells bind greater amounts of [3H]vinblastine than do vesicles from drug-sensitive cells (16) 8- azido-[32P]ATP photoaffinity label P-glycoprotein in membrane preparations from multidrug-resistant cells (17) (18) (19) , indicating that P-glycoprotein is a drug-and ATP-binding protein. In this paper, we demonstrate that P-glycoproteincontaining membrane vesicles prepared from multidrugresistant KB cells transport [3H]vinblastine in an ATPdependent manner. ATP hydrolysis appeared to be required for this transport. Vinblastine transport was inhibited by daunomycin, actinomycin D, vincristine, puromycin, and colchicine and also by verapamil and quinidine, agents that overcome multidrug resistance.
MATERIALS AND METHODS
Vesicle Preparation and Characterization. Crude membrane vesicles were prepared from drug-sensitive and drug-resistant (KB-Vi) human KB carcinoma cell lines (20, 21) by nitrogen cavitation (22) as previously described (16) . These preparations were enriched 3-to 4-fold in Na+,K+-ATPase activity compared to whole homogenates (16) . The crude membrane vesicles were then suspended in buffer A (10 mM Tris HCl, pH 7.5/0.25 M sucrose), layered onto a 20%/30%o/50%o discontinuous sucrose gradient in 10 mM Tris HCl, and centrifuged for 15 hr at 100,000 x g. Vesicles at the 30%/50% interface were collected, diluted in buffer A, and centrifuged for 50 min at 100,000 x g. The vesicle pellet was resuspended in buffer A by use of a 25-gauge needle. Vesicles were stored at -70°C prior to use. Relative to the homogenate, the activity of 5'-nucleotidase (a plasma membrane marker) in the final vesicle fraction was enriched =7-fold. There was no difference in enrichment of this enzyme activity between membrane vesicles from drugsensitive and drug-resistant cells. By electron microscopic analysis, most of the structures had the appearance of plasma membrane vesicles.
[3H]Vinblastine Uptake by Vesicles (Fig. 1) , intravesicular transport must be against a concentration gradient.
ATP Hydrolysis Is Required for Vinblastine Transport. ATP-dependent vinblastine uptake was measured as a function of ATP concentration to determine an apparent Km for ATP in the transport process. ATP stimulated vinblastine uptake in a saturable manner (Fig. 3A) . These data were replotted as uptake/[ATP] vs. uptake (Eadie-Hofstee plot; Fig. 3B ). From this linear plot it is possible to calculate that ATP reacts with the transporter with Michaelis-Menten kinetics with an apparent Km = 38 ,LM. known to be handled by the mdr transport system and in the presence of verapamil and quinidine. Vincristine, actinomycin D, verapamil, and quinidine were all found to be potent inhibitors of uptake (IC50 < 5 ,uM), whereas daunomycin was less effective (IC50 -30 MM). Puromycin and colchicine inhibited transport at >100 ,uM. These data are summarized in Table 1 .
To determine whether inhibition by drugs was competitive or noncompetitive, a more detailed kinetic analysis was conducted for daunomycin inhibition of vinblastine uptake. Fig. SB (23) . In this paper we show that there is an active vinblastinetransport system energized by ATP in membrane vesicles IC50 is the concentration of the agent that inhibits vinblastine transport by 50%. *ATP concentration in these experiments was 100 ,uM; in all other experiments shown here it was 300 ,tM. from multidrug-resistant cells. The ATP-dependent stimulation of vinblastine uptake and the osmosensitivity of this process indicate that true transport, and not vinblastine binding to membranes, has been measured. Transport occurs from the incubation medium to the interior of the vesicle, suggesting that those vesicles that are transporting drug into their interior are probably inside-out, because drug-resistant cells normally transport drug from the cytoplasm to the extracellular space. Because this transporter was not found in vesicles derived from drug-sensitive cells, these results confirm the hypothesis that multidrug resistance results from the presence of an energy-dependent transport system in plasma membranes of drug-resistant cells. The product of the MDR] gene, P-glycoprotein, binds the drugs under study (16) (17) (18) , as well as ATP (19) , and is present in these transporting membrane vesicles (refs. DNA sequence data show two potential ATP binding sites on P-glycoprotein (11, 12) , but the kinetic analysis of transport shown here indicates that the ATP requirement has a hyperbolic concentration curve and a linear Eadie-Hofstee plot, consistent with the use of a single ATP binding site for vinblastine transport. The fact that two very similar ATP binding sites are conserved suggests that both sites have an important function. The nonhydrolyzable ATP analog AdoPP[NH]P is not a substrate for the enzyme but is a competitive inhibitor of ATP, suggesting that ATP hydrolysis is needed for transport and that ATP is not simply an allosteric activator. The inhibition of transport by the ATPase inhibitor vanadate also supports the conclusion that ATPase activity is required for vinblastine transport.
These studies also provide data indicating that there are a limited number of drug-transporting sites on the transporter. Many cytotoxic drugs to which multidrug-resistant lines are resistant, including vincristine, actinomycin D, and daunomycin, were found to be good inhibitors of the vinblastine transport (Table 1 ). In the case of daunomycin, we showed that this inhibition was competitive. Colchicine and puromycin were less effective inhibitors of vinblastine transport. Colchicine was also a poor inhibitor of [3H]vinblastine binding to membrane vesicles (17) , suggesting the possibility that there may be a second binding and transport site for colchicine on P-glycoprotein, or that colchicine is simply not as good a substrate for the transporter because it does not bind as well to P-glycoprotein. Verapamil and quinidine, which reverse drug resistance and also inhibit [125I]NASV binding to P-glycoprotein (18), were potent inhibitors of the transport process as well. These results indicate that this transport assay may provide an extremely sensitive screening test for agents that reverse multidrug resistance.
Recent data suggest that expression of the MDR] gene is associated with intrinsic and acquired multidrug resistance in human cancer (23) (24) (25) (26) . The complete characterization of the transport system described here will allow the development of new approaches to the circumvention of this impediment to successful cancer chemotherapy.
